KL
Keun Woo Lee
Angel i-Drug Design (AiDD), Korea Quantum Computing (KQC), Seoul National University, Gyeongsang National University
Research areas: Pharmacology, Toxicology and Pharmaceutics · Drug Discovery · Computational Drug Discovery Methods · Synthesis and Characterization of Heterocyclic Compounds · Cholinesterase and Neurodegenerative Diseases
0000-0002-0627-1800
Employment
-
Korea Quantum Computing (KQC) CTO2024 - 2026
-
Angel i-Drug Design (AiDD) CEO2022 - Present
-
Gyeongsang National University Professor2004 - 2021
Education
- 1990 - 1997
- 1988 - 1990
- 1984 - 1988
Projects & Funding
Projects & funding information is unavailable.
Publications (478)
- Identification of a novel small-molecule inhibitor of the HIV-1 reverse transcriptase activity with a non-nucleoside mode of action Save
- Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s disease Save
- Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s disease Save
- C-Type LECTIN receptor-like kinase 1 and ACTIN DEPOLYMERIZING FACTOR 3 are key components of plasmodesmata callose modulation Save
- C-Type LECTIN receptor-like kinase 1 and ACTIN DEPOLYMERIZING FACTOR 3 are key components of plasmodesmata callose modulation Save
- Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach Save
- Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach Save
- Discovery of Novel Allosteric SHP2 Inhibitor Using Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation, and Principal Component Analysis Save
- Discovery of novel allosteric SHP2 inhibitor using pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and principal component analysis Save
- Modeling of FAK-PROTAC candidates from GSK2256098 analogs for targeted protein degradation Save
- Modeling of FAK-PROTAC candidates from GSK2256098 analogs for targeted protein degradation Save
- New SARS-CoV-2 Mpro Inhibitor by Ascorbic Acid: Design, Molecular Docking, Lipinski’s Rule and ADMET Analysis Save
- New SARS-CoV-2 Mpro Inhibitor by Ascorbic Acid: Design, Molecular Docking, Lipinski’s Rule and ADMET Analysis Save
- Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations Save
- Uncovering potential CDK9 inhibitors from natural compound databases through docking-based virtual screening and MD simulations Save
- Unveiling the Mechanisms Underlying the Immunotherapeutic Potential of Gene–miRNA and Drugs in Head and Neck Cancer Save
- Unveiling the mechanisms underlying the immunotherapeutic potential of Gene--miRNA and drugs in head and neck cancer Save
- A review on Millepachine and its derivatives as potential multitarget anticancer agents Save
- A review on Millepachine and its derivatives as potential multitarget anticancer agents Save
- An overview on monkeypox virus: Pathogenesis, transmission, host interaction and therapeutics Save